Grossing+

Grossing+ is an AI-driven specimen documentation tool developed by Lumea, built around the BxCamera® machine-learning platform. It is designed for pathology labs and grossing stations, and has been used on over 2 million specimens. The system measures and documents specimens in seconds, targeting labs that want to reduce manual effort, minimize human variation, and improve throughput at the grossing station.

The tool is available either as an integrated solution that connects with existing Laboratory Information Systems (LIS) via an open API, or as a standalone plug-and-play unit for labs that prefer to operate without direct LIS integration.

Core Features

• Automatic documentation and measurement of any specimen that fits within a cassette, completed in seconds.
• Automatic grossing template builders to standardize documentation workflows.
• Multiplexing capabilities to handle multiple specimens efficiently.
• Accurate length and width measurement, individual fragment documentation, and aggregate measurement of multiple pieces.
• Versatile specimen processing across a variety of specimen types, including prostate core biopsies.

Standardization and Quality Assurance

• Reduces risks and errors associated with manual grossing by providing consistent, precise measurements.
• Eliminates human variation in gross descriptions, supporting quality assurance across the lab.
• Produces high-quality, reproducible documentation for each specimen processed.

Software Integration

• Open API framework supports integration with any existing LIS.
• Auto-populates specimen information directly into the connected LIS, reducing manual data entry.
• Standalone, plug-and-play version available for labs that do not require LIS integration, with the same Smart features that can be manually added to an LIS.

Tissue-Handling Device Compatibility

• Compatible with Lumea's pre-analytical specimen collection and transportation devices.
• These devices are designed for use in procedures and labs to standardize specimen handling, reduce fragmentation, increase tissue yield for microscopy, and maintain anatomic orientation.

Grossing+ is developed by Lumea, based in Lehi, UT. Users should note that BxLink has not been approved by the FDA for digital primary diagnosis; CAP guidelines regarding the use of digital pathology technologies apply.